•  

Browse and digest the latest news in neurosurgery

Message from NEUROSURGIC

Please observe that

we do not have the possibilty to

add more conferences

for the moment

 
News_210x100.jpg

NeuRx.jpgNeuRx Diaphragm Pacing System for treating ALS

Synapse Biomedical, Inc. announces in a News Release that the U.S. FDA has approved NeuRx Diaphragm Pacing System (DPS)® for treating amyotrophic lateral sclerosis (ALS) patients who have stimulatable diaphragms and are experiencing chronic hypoventilation.

The FDA Humanitarian Device Exemption (HDE) marketing approval is based on demonstration that NeuRx DPS® could help ALS patients live longer and sleep better than the current standard of care, alone. These findings are the result of a multicenter clinical trial.


Read more on Medgadget.

 

Comments (0)Add Comment

Write commentWrite Comment

You must be logged in to post a comment. Please register if you do not have an account yet.

busy
You are here: